Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues.

Xenobiotica; the fate of foreign compounds in biological systems - 1 Dec 1998

Tucker G T, Rostami-Hodjegan A, Jackson P R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Caffeine
Share to Cytochrome P-450 Enzyme System
Share to Inactivation, Metabolic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Models, Biological

Share to Models, Statistical

Share to Pharmacokinetics

Share to Reproducibility of Results

Source

Identifiers

PMID: 9890160
DOI: 10.1080/004982598238895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues.PMID 9890160Read ↗

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effectsSemantic proximity Read ↗

Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.Semantic proximity Read ↗

[Phenotyping of enzymes participating in drug metabolism].Semantic proximity Read ↗

Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro ModelsSemantic proximity Read ↗

Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implicationsSemantic proximity Read ↗

In vitro ADME phenotyping in drug discovery: current challenges and future solutions.Semantic proximity Read ↗

[Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].Semantic proximity Read ↗

Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.Semantic proximity Read ↗

Phenotyping of drug metabolism in infants and children: potentials and problems.Semantic proximity Read ↗

Problems and perspectives of phenotyping for drug-metabolizing enzymes in man.Semantic proximity Read ↗

Human cytochrome P450s: selectivity and measurement in vivoSemantic proximity Read ↗

In vivo and in vitro measurement of CYP2C19 activity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.